0.8228

0.56% 0.0046

Rockwell Medical Inc (RMTI)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$0.8182

Offen:

$0.81

24-Stunden-Volumen:

160.88K

Relative Volume:

0.66

Marktkapitalisierung:

$35.29M

Einnahmen:

$98.92M

Nettoeinkommen (Verlust:

$-1.24M

KGV:

-13.71

EPS:

-0.06

Netto-Cashflow:

$2.64M

1W Leistung:

+1.71%

1M Leistung:

-18.53%

6M Leistung:

-64.69%

1J Leistung:

-53.46%

1-Tages-Spanne:

$0.81

$0.8551

1-Wochen-Bereich:

$0.7857

$0.8671

52-Wochen-Spanne:

$0.7801

$5.15

Rockwell Medical Inc Stock (RMTI) Company Profile

Firmenname

Rockwell Medical Inc

Sektor

Healthcare (1160)

Branche

Drug Manufacturers - Specialty & Generic (83)

Telefon

(800) 449-3353

Adresse

30142 WIXOM ROAD, WIXOM, NJ

Mitarbeiter

244

Twitter

@rockwellmedical

Nächster Verdiensttermin

2024-11-11

Neueste SEC-Einreichungen

RMTI's Discussions on Twitter

Vergleichen Sie RMTI mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
RMTI Rockwell Medical Inc	0.8228	35.29M	98.92M	-1.24M	2.64M	-0.06
RGC Regencell Bioscience Holdings Ltd	22.99	303.95B	0	-5.87M	-767.30K	-0.45
ZTS Zoetis Inc	159.18	74.39B	9.29B	2.52B	2.28B	5.57
HLN Haleon Plc Adr	10.25	48.97B	14.35B	1.85B	0	0.4023
TAK Takeda Pharmaceutical Co Adr	15.34	47.39B	30.08B	710.16M	4.45B	0.2182
TEVA Teva Pharmaceutical Industries Ltd Adr	17.01	20.17B	16.54B	-1.64B	749.00M	-1.45

Rockwell Medical Inc Stock (RMTI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-11-14	Eingeleitet	Rodman & Renshaw	Buy
2019-06-24	Eingeleitet	Piper Jaffray	Overweight
2019-05-13	Eingeleitet	H.C. Wainwright	Buy
2016-11-08	Herabstufung	BofA/Merrill	Neutral → Underperform
2016-03-01	Herabstufung	Stifel	Buy → Hold
2015-08-13	Eingeleitet	Morgan Stanley	Underweight
2015-01-27	Bestätigt	Oppenheimer	Outperform
2015-01-07	Eingeleitet	Oppenheimer	Outperform
2014-08-14	Eingeleitet	FBR Capital	Underperform
2013-12-19	Eingeleitet	Chardan Capital Markets	Buy
2013-11-06	Bestätigt	Summer Street Research	Buy
2013-09-05	Bestätigt	Summer Street Research	Buy
2013-08-02	Bestätigt	Summer Street Research	Buy
2012-04-11	Eingeleitet	Summer Street Research	Buy
2012-03-12	Eingeleitet	Stifel Nicolaus	Buy
2012-01-03	Eingeleitet	Canaccord Genuity	Buy
2009-12-10	Eingeleitet	JMP Securities	Mkt Outperform
2009-10-12	Eingeleitet	Wedbush Morgan	Outperform

Alle ansehen

Rockwell Medical Inc Aktie (RMTI) Neueste Nachrichten

Jun 17, 2025

Intravenous Iron Drugs Market to Reach USD 6.63 Bn by 2032 - newstrail.com

Jun 17, 2025

Jun 14, 2025

Rockwell Medical (NASDAQ:RMTI) Raised to Hold at Wall Street Zen - Defense World

Jun 14, 2025

Jun 13, 2025

Millennium Management LLC Cuts Position in Rockwell Medical, Inc. (NASDAQ:RMTI) - Defense World

Jun 13, 2025

Jun 07, 2025

RMTIRockwell Medical Announces First Quarter 2025 Results - Revista ADVFN

Jun 07, 2025

Jun 06, 2025

Dialysis Equipment Market to Reach $191.24 Bn by 2032 - newstrail.com

Jun 06, 2025

May 29, 2025

Key Market Driver in intravenous iron drugs Industry 2025: RisinNORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA

May 29, 2025

May 26, 2025

Iron Deficiency Anemia Market Accelerates with Health Programs - openPR.com

May 26, 2025

May 24, 2025

Rockwell Medical (NASDAQ:RMTI) Downgraded to “Sell” Rating by Wall Street Zen - Defense World

May 24, 2025

May 22, 2025

Dialysate Market Insights: Growing at 6.04% CAGR to USD 9.8 Billion by 2031 - openPR.com

May 22, 2025

Dimensional Fund Advisors LP Invests $146,000 in Rockwell Medical, Inc. (NASDAQ:RMTI) - Defense World

May 18, 2025

May 15, 2025

Raymond James Financial Inc. Invests $28,000 in Rockwell Medical, Inc. (NASDAQ:RMTI) - Defense World

May 15, 2025

May 14, 2025

Rockwell Medical reiterates $65M–$70M 2025 sales guidance while pursuing new customers and product expansion - MSN

May 14, 2025

May 13, 2025

Rockwell Medical, Inc. (NASDAQ:RMTI) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025